# Tamoxifen Study

> **NCT00000529** · PHASE3 · COMPLETED · sponsor: **NSABP Foundation Inc**

## Conditions studied

- Cardiovascular Diseases
- Coronary Disease
- Heart Diseases
- Hypertension
- Myocardial Ischemia

## Interventions

- **DRUG:** tamoxifen

## Key facts

- **NCT ID:** NCT00000529
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-05
- **Primary completion:** —
- **Final completion:** 1995-11
- **Target enrollment:** — (—)
- **Last updated:** 2016-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000529, "Tamoxifen Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00000529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*